{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-072284","form_type":"8-K","ticker":null,"cik":"0001811623","company_name":"PaxMedica, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.758764+00:00","generated_at":"2026-06-13T23:05:43.814179+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"PaxMedica receives Nasdaq delisting notice for failing Minimum Market Value Rule; plans appeal","bullets":["Nasdaq staff notified PaxMedica on June 12, 2023 that it failed to regain compliance with the $35M market value requirement.","Common stock (PXMD) subject to delisting from Nasdaq Capital Market unless a hearing is requested by June 20, 2023.","Company intends to request a hearing to appeal the delisting determination; hearing request will stay suspension pending decision.","No assurance that the appeal will be successful or that continued listing will be granted."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-072284","json":"https://secwatch.observer/filing/0001104659-23-072284.json","markdown":"https://secwatch.observer/filing/0001104659-23-072284.md","text":"https://secwatch.observer/filing/0001104659-23-072284.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811623/000110465923072284/0001104659-23-072284-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811623/000110465923072284/tm2318486d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:05:43.814179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d0c3424b0a916d4c694049f8d6728f7a627fd54","claim":"PaxMedica, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"June 12, 2023, PaxMedica, Inc. (the “ Company ”) received a determination letter (the “ Letter ”) from the staff (the “ Staff ”) of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that the Company has not regained compliance with Listing Rule 5550(b)(2) (the “ Minimum Market Value Requirement ”), requiring the Company to maintain a market value of listed securities of a minimum of $35 million, during the 180-day grace period previously granted to the Company. As previously disclosed, the Company was initially notified by the Staff on December 6, 2022 t","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1811623/000110465923072284/0001104659-23-072284-index.htm","confidence":0.97,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}